The Effect of Virtual Reality Application on Independence and Hand Functions in Daily Life in Children With CP
Launched by HACETTEPE UNIVERSITY · Mar 12, 2024
Trial Information
Current as of June 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how virtual reality (VR) programs can help children with hemiplegic cerebral palsy improve their independence and use of their hands in everyday activities. The researchers want to see if using VR in addition to regular therapy can make a difference in how well these children can function. The trial will involve children aged 6 to 12 who are diagnosed with hemiplegic cerebral palsy and do not have certain physical limitations or recent surgeries.
Children who join the study will be split into two groups. One group will receive VR training along with their usual therapy for three weeks, while the other group will continue with just their regular therapy. Before and after the trial, the researchers will check how well the children's hands work and how independent they feel in daily tasks. This study aims to find out if adding VR can effectively support the rehabilitation process for these children, helping them to gain more skills and confidence in their daily lives.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - Having a diagnosis of hemiplegic SP
- • Being between the ages of 6-12
- • Not having any fixed contracture in the upper extremity
- • According to the Modified Ashworth Scale, the upper extremity spasticity value is at the level of 1,1+,2 or 3
- • Being at level I, II or III according to the Gross Motor Function Classification System (GMFCS)
- • Being at level II or III according to the Manual Ability Classification System (MACS)
- • Being at level I, II or III according to the Communication Function Classification System (CFCS)
- • Being within the normal cognitive level according to the Modified Pediatrics Mini Mental Test score
- • Being at level I, II or III according to the Eating and Drinking Ability Classification System (EDACS)
- • Being at level I, II or III according to the Visual Function Classification System for Children with Cerabral Palsy (VFCS)
- • Volunteering to participate in the study
- Exclusion Criteria:
- • Having botolinum toxin injection within the last 6 months
- • Having undergone a surgical procedure within the last 1 year
- • Fracture, trauma, etc. in the upper extremity. to live
About Hacettepe University
Hacettepe University is a leading research institution in Turkey, renowned for its commitment to advancing medical science and healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, the university supports a wide range of clinical trials aimed at improving patient outcomes and developing new therapeutic approaches. Hacettepe University is dedicated to maintaining the highest ethical standards and regulatory compliance in its research endeavors, fostering an environment that promotes scientific excellence and contributes to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Multiple Locations, Ankara, Turkey
Patients applied
Trial Officials
Başak Karadağ, MSc
Principal Investigator
Ankara City Hospital Bilkent
Meral Huri, Professor
Study Director
Hacettepe University
Berke Aras, Ass.Prof.
Principal Investigator
Ankara City Hospital Bilkent
Özge Tezen, MD
Study Chair
Ankara City Hospital Bilkent
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported